These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 12180882

  • 1. Derivation, safety and efficacy of a Marek's disease vaccine developed from an Australian isolate of very virulent Marek's disease virus.
    Karpathy RC, Firth GA, Tannock GA.
    Aust Vet J; 2002; 80(1-2):61-6. PubMed ID: 12180882
    [Abstract] [Full Text] [Related]

  • 2. Characterization of four very virulent Argentinian strains of Marek's disease virus and the influence of one of those isolates on synergism between Marek's disease vaccine viruses.
    Buscaglia C, Nervi P, Risso M.
    Avian Pathol; 2004 Apr; 33(2):190-5. PubMed ID: 15276986
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Serotype specificity of B-haplotype influence on the relative efficacy of Marek's disease vaccines.
    Bacon LD, Witter RL.
    Avian Dis; 1994 Apr; 38(1):65-71. PubMed ID: 8002902
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H, Quanz S, Suurland B, Spijkers IE, Rodenberg J, Davelaar FG, Jongsma B, Kumar M.
    Vaccine; 2008 Oct 16; 26(44):5595-600. PubMed ID: 18706949
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K, Witter RL, Lee LF, Yanagida N.
    Avian Dis; 1996 Oct 16; 40(2):368-76. PubMed ID: 8790888
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Attenuated revertant serotype 1 Marek's disease viruses: safety and protective efficacy.
    Witter RL.
    Avian Dis; 1991 Oct 16; 35(4):877-91. PubMed ID: 1664721
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Properties of a meq-deleted rmd5 Marek's disease vaccine: protection against virulent MDV challenge and induction of lymphoid organ atrophy are simultaneously attenuated by serial passage in vitro.
    Lee LF, Kreager K, Heidari M, Zhang H, Lupiani B, Reddy SM, Fadly A.
    Avian Dis; 2013 Jun 16; 57(2 Suppl):491-7. PubMed ID: 23901766
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Relationship between the immunosuppressive potential and the pathotype of Marek's disease virus isolates.
    Calnek BW, Harris RW, Buscaglia C, Schat KA, Lucio B.
    Avian Dis; 1998 Jun 16; 42(1):124-32. PubMed ID: 9533089
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Serotype 1 viruses modified by backpassage or insertional mutagenesis: approaching the threshold of vaccine efficacy in Marek's disease.
    Witter RL, Kreager KS.
    Avian Dis; 2004 Dec 16; 48(4):768-82. PubMed ID: 15666858
    [Abstract] [Full Text] [Related]

  • 20. Vaccination-challenge interval markedly influences protection provided by Rispens CVI988 vaccine against very virulent Marek's disease virus challenge.
    Islam T, Walkden Brown SW, Renz KG, Fakhrul Islam AF, Ralapanawe S.
    Avian Pathol; 2013 Dec 16; 42(6):516-26. PubMed ID: 24098951
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.